Bionomics to enter clinical trials for cancer stem cell drug candidate – Proactive Investors Australia
Proactive Investors Australia |
Bionomics to enter clinical trials for cancer stem cell drug candidate
Proactive Investors Australia … target cancer stem cells will reduce the risk of cancer recurrence and metastasis and lead to better patient outcomes. Preclinical studies have been promising and demonstrated efficacy in models of colon, pancreatic, breast and small cell lung cancer. |
